We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approval for Genentech’s Subcutaneous Rituximab

News   Mar 31, 2017 | Original Story from Genentech

 
FDA Approval for Genentech’s Subcutaneous Rituximab
 
 
Advertisement
 

RELATED ARTICLES

New Quantum Microscope Reveals Biological Detail Otherwise Impossible To See

News

Researchers have created a quantum microscope that can reveal biological structures that would otherwise be impossible to see.

READ MORE

Janssen COVID-19 Vaccine Generates Immune Response Against Variants

News

A study reports that the Ad26.COV2.S vaccine induced immune responses against all viral variants.

READ MORE

COVID-19 Vaccine Is Safe and Efficacious in Cancer Patients

News

In a review of 200 patients with a wide spectrum of cancer diagnoses, researchers at Montefiore Health System and Albert Einstein College of Medicine in the Bronx, NY, found that after full vaccination, 94% of patients overall demonstrated seroconversion, which was determined by the presence of antibodies to the SARS-CoV-2 spike protein.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE